Registration
 
All news
Editors' Picks
Crypto News
Financial News
Market Voices
Billionaires
Companies
Broker News
Regulators News
Anastasiia Chabaniuk
Anastasiia Chabaniuk

Caribou Biosciences receives FDA RMAT designation for CB-011 in multiple myeloma

Caribou Biosciences receives FDA RMAT designation for CB-011 in multiple myeloma
Caribou wins FDA RMAT for CB-011

Caribou Biosciences announced that the U.S. Food and Drug Administration has granted CB-011, its allogeneic cell therapy, the RMAT (Regenerative Medicine Advanced Therapy) designation for the treatment of relapsed or refractory multiple myeloma.

The designation is expected to accelerate the clinical development and regulatory review of CB-011, which leverages CRISPR technology to target cancer cells. The RMAT status provides enhanced guidance and streamlined communication with the FDA, potentially expediting patient access to innovative cell therapies.

Caribou Biosciences recently unveiled its Q4 and FY2025 financial results, providing an update on its recent performance and fiscal outlook. The company is advancing its CRISPR-based therapeutics portfolio alongside this financial disclosure. Market participants continue to monitor Caribou’s progress in clinical development and regulatory milestones.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

Trading thin air: Why Binance is closing its NFT marketplace
  • By Oleg Tkachenko
  • 8 hours ago
Trading thin air: Why Binance is closing its NFT marketplace
Editors' Picks
Bitcoin without investors: Why IPOs are winning attention
  • By Eugene Komchuk
  • Yesterday
Bitcoin without investors: Why IPOs are winning attention
Editors' Picks
Bitcoin price prediction based on MACD: Bearish momentum gains strength
  • By Anastasiia Chabaniuk
  • 02.06.2026
Bitcoin price prediction based on MACD: Bearish momentum gains strength
Editors' Picks
All Editors' Top Picks

Latest Caribou News

Caribou Biosciences prepares to attend Jefferies Global Healthcare Conference in New York
  • By Artem Shendetskii
  • 27.05.2026
Caribou Biosciences prepares to attend Jefferies Global Healthcare Conference in New York
Companies
#Caribou
Caribou Biosciences brings CMO and CFO to BioConnect Investor Conference fireside chat
  • By Oleg Tkachenko
  • 18.05.2026
Caribou Biosciences brings CMO and CFO to BioConnect Investor Conference fireside chat
Companies
#Caribou
Caribou Biosciences attends BioConnect Investor Conference in New York next week
  • By Artem Shendetskii
  • 13.05.2026
Caribou Biosciences attends BioConnect Investor Conference in New York next week
Companies
#Caribou
All Caribou News
  • Oleg Tkachenko
  • 8 hours ago
Trading thin air: Why Binance is closing its NFT marketplace
  • Eugene Komchuk
  • Yesterday
Bitcoin without investors: Why IPOs are winning attention
  • Anastasiia Chabaniuk
  • 02.06.2026
Bitcoin price prediction based on MACD: Bearish momentum gains strength
  • Kyle Torpey
  • 01.06.2026
Ethereum's identity crisis: Between Wall Street and cypherpunk
  • Eugene Komchuk
  • 01.06.2026
Europe and U.S. prepare crypto taxes: How their approaches differ
  • Daria Chernytska
  • 4 min ago
Laura Shin: CFTC regulation distinguishes derivatives from gambling on Kalshi, Polymarket
  • Yaroslav Dmytrenko
  • 4 min ago
Portfolio could reach $325 million by investing $500 each Bitcoin decline, Davinci Jeremie notes
  • Artem Shendetskii
  • 4 min ago
Inflation and energy prices from Iran war featured, Alex Jones discusses
  • Hanna Syniavska
  • 13 min ago
Brad Mills: Plans to buy bitcoin with excess cashflow
  • Jose Antonio Gastelum
  • 14 min ago
Mario Nawfal: Litecoin overcomes competition as enduring crypto survivor
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.
Top News
  • Olga Shendetskaya
  • 6 hours ago
Coinbase launches SpaceX pre-IPO futures
Coinbase launches SpaceX pre-IPO futures
  • Igor Krasulya
  • 6 hours ago
S&P 500 futures fall as Iran tensions snap 9-day winning streak
S&P 500 futures fall as Iran tensions snap 9-day winning streak
  • Ivan Andriyenko
  • 8 hours ago
SpaceX IPO could lift Elon Musk's net worth above $1 trillion
SpaceX IPO could lift Elon Musk's net worth above $1 trillion
  • Anastasiia Chabaniuk
  • 9 hours ago
Coinbase freezes $3M as U.S. targets Southeast Asia scam rings
Coinbase freezes $3M as U.S. targets Southeast Asia scam rings
  • Olga Shendetskaya
  • 10 hours ago
Oil falls as Israel-Lebanon ceasefire eases Gulf risk
Oil falls as Israel-Lebanon ceasefire eases Gulf risk
Live News
  • Anton Kharitonov
  • Now
Alphabet declines amid $80 billion share issuance and AI investments
  • Anton Kharitonov
  • Now
Microsoft remains under pressure despite AI breakthroughs
  • Anton Kharitonov
  • Now
Apple pulls back after reaching new highs
  • Anton Kharitonov
  • Now
Bitcoin remains under pressure as market awaits new source of demand
  • Dmytro Kharkov
  • Now
AMD faces pullback risk as technology sector weakens
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org World Association of News Publishers https://gdpr.eu/ GDPR